Search Results
Dec 17, 2025, 09:00 ET Ultromics Secures Strategic Investment from the American Heart Association's Go Red for Women Venture Fund™
been expected to diagnose it using tools that weren't built to detect it, and as a result, many patients are identified too late," said Ross Upton, PhD, CEO and Founder of Ultromics. "By augmenting physicians' decision making with EchoGo, we can help them recognize disease at an earlier stage and treat
More news about: Ultromics
Dec 17, 2025, 09:00 ET Northwell Health and START Center for Cancer Research unveil world-class early-phase cancer clinical trial center
Geraldine O'Sullivan Coyne, MD, PhD, system head of Northwell START New York-Long Island and principal investigator for The START Center for Cancer Research. She is an internationally
More news about: The START Center for Cancer Research
Dec 17, 2025, 08:38 ET Jeonbuk National University Researchers Reveal New Interface Engineering Strategy for Efficient and Stable Back-Contact Solar Cells
research team led by Associate Professor Min Kim from the Department of Chemical Engineering, University of Seoul, Republic of Korea and Mr. Dohun Baek, a PhD student from the School of Chemical Engineering, Jeonbuk National University, Republic of Korea, has developed a novel bilayer tin oxide (SnO2)
More news about: Jeonbuk National University
Dec 17, 2025, 08:30 ET Enhancing Signal Detection and Mitigating Placebo Response in Major Depressive Disorder Clinical Trials, Upcoming Webinar Hosted by Xtalks
response and improve clinician-rated outcomes in MDD clinical trials.Join experts from Cogstate, Luka Lucić, PhD, Senior Director, Clinical Science, Psychiatry; and Svenja Wacker, PhD, Neuropsychology Science Director, for the live webinar on Wednesday, January 21, 2026, at 11am EST (5pm CET/EU-Central).For
More news about: Xtalks
Dec 17, 2025, 08:30 ET Quantum Computing Inc. Confirms Dr. Yuping Huang as Chief Executive Officer to Lead Global Growth
ten-year technology roadmap and long-term vision.Dr. Huang brings over 20 years of leadership in quantum physics and technology. He earned a PhD in quantum AMO physics and has held faculty and research leadership roles at Northwestern University and Stevens Institute of Technology. He has led
More news about: Quantum Computing Inc.
Dec 17, 2025, 08:30 ET Survey: New Yorkers Demand Businesses Prioritize the Security and Resilience of Their Data - And are Penalizing Those that Don't
here."New York City is a microcosm of what we're seeing in the rest of the country," said Jessica Barker, MBE, PhD, co-CEO, Cygenta. "Consumer expectations tied to security and resilience have never been higher for businesses, and that's only going
More news about: COMMVAULT
Dec 17, 2025, 08:03 ET Purina Awards $120,000 in Global Research Grants to Advance Understanding of the Human-Pet Bond
in IPV-Affected Households: Impacts on Survivor Healing, Pet Welfare and Service ProvisionPrincipal Investigator: Jennifer A. Wagman, PhD, MHS, at the Jonathan and Karin Fielding School of Public Health at the University of California, Los Angeles in Los Angeles, CaliforniaThis
More news about: Purina
Dec 17, 2025, 07:30 ET Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis
thicker lesions found in psoriasis."We are pleased with the preliminary findings from our ongoing Phase 2a trial," stated Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix. "The optimized gel formulation was designed to improve the patient experience, with both easier
More news about: SOLIGENIX, INC.
Dec 17, 2025, 06:50 ET Protalix Biotherapeutics and Secarna Pharmaceuticals Enter into Collaboration and Option Agreement
[email protected] ContactKonstantin Petropoulos, PhD, MBACEOPhone: +49 (0)89 215 46 [email protected]
More news about: Protalix BioTherapeutics, Inc.; Secarna Pharmaceuticals
Dec 17, 2025, 06:45 ET PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
signaling a shift from conventional platinum-based chemotherapy and the potential to transform the standard of care."Moitreyee Chatterjee-Kishore, PhD, MBA, Head of Oncology Development, Astellas"Building on the recent U.S. approval for cisplatin-ineligible patients living with MIBC, these
More news about: Astellas Pharma Inc.
Dec 16, 2025, 19:04 ET Harbour BioMed Enters into Global Strategic Collaboration and License Agreement with Bristol Myers Squibb to Discover and Develop Next-Generation Multi-Specific Antibodies
milestones of up to $1.035 billion, along with tiered royalties should Bristol Myers Squibb elect to advance all potential programs.Jingsong Wang, MD, PhD, Founder, Chairman, and CEO of Harbour BioMed, commented: "We are delighted to collaborate with Bristol Myers Squibb to advance next-generation multi-specific
More news about: Harbour BioMed
Dec 16, 2025, 16:00 ET RIVANNA announces FDA clearance of Accuro 3S Needle Guide Kit
commitment to providing clinicians with intuitive, workflow-enhancing tools that enhance procedural accuracy and patient safety," said Will Mauldin, PhD, Co-founder and CEO of RIVANNA. "The patient drape's stabilization bands, which secure the transducer for hands-free positioning, further distinguish
More news about: RIVANNA
Dec 16, 2025, 15:40 ET Improve Effectiveness of Cardiac Assessments in Early Phase Trials with Early Precision QT and AI-powered Data Quality Checks, Upcoming Webinar Hosted by Xtalks
qualify for a TQT waiver.Join Vic Patel (Moderator), MD, PhD, Vice President & Chief Medical Officer, Cardiology, Clario; Dr. Borje Darpo, MD, PhD, Chief Scientific Officer, Cardiac Safety, Clario; and Jean-Philippe Couderc, PhD, MBA, Professor of Medicine and Computer/Electrical Engineering,
More news about: Xtalks
Dec 16, 2025, 15:39 ET Bioassay Method Transfer Strategies to Reduce Variability, Upcoming Webinar Hosted by Xtalks
BioAgilytix, Jessica Weaver (Moderator), MRes, Scientific Officer, CMC; Katie Harcher, MS, Bioanalytical Project Manager; Julia Hecker, PhD, Principal Investigator; and Leigh Laundon, PhD, Manager I, for the live webinar on Wednesday, January 14, 2026, at 10am EST (4pm CET/EU-Central).For more information,
More news about: Xtalks
Dec 16, 2025, 13:40 ET UT San Antonio announces transformational $30 million gift from the Kate Marmion Charitable Foundation for the Kate Marmion School of Public Health
joint vision of the late William L. Henrich, MD, former president of UT Health San Antonio, and UT San Antonio President Taylor Eighmy, PhD, the Kate Marmion School of Public Health serves as the region's comprehensive academic home for public health – educating future professionals, advancing
More news about: UT Health San Antonio
Dec 16, 2025, 10:56 ET AMERICAN SKIN ASSOCIATION (ASA) ANNOUNCES RELOCATION OF HEADQUARTERS TO CHARLOTTESVILLE AND WELCOMES NEW MEDICAL ADVISORY COMMITTEE MEMBER, LU Q. LE, MD, PHD
to combat melanoma, skin cancer, and other skin diseases.In conjunction with this transition, ASA announced the appointment of Lu Q. Le, MD, PhD to its Medical Advisory Committee as the Virginia Scientific Advisor. Dr. Le is a distinguished expert in cancer biology and became the Chair of the
More news about: American Skin Association
Dec 16, 2025, 08:34 ET Advancium Health Network Names Michele Cleary CEO to Drive Next Phase of Pediatric Healthcare Innovation
Dec. 16, 2025 /PRNewswire/ -- Advancium Health Network and its nonprofit subsidiary CobiCure today announced the appointment of Michele Cleary, PhD, to Chief Executive Officer. Dr. Cleary, previously Advancium's President and Chief Scientific Officer, brings more than two decades of leadership in
More news about: Advancium Health Network
Dec 16, 2025, 08:32 ET The Coordinating Center's New Website Sets Standard for Accessible, Person-Centered Care
and individuals interested in joining our team. "Accessibility and inclusion are at the heart of everything we do," said Teresa Titus-Howard, PhD, MHA, MSW, CCM, President and CEO. "Our new website ensures that everyone, regardless of ability, can connect with our team, learn about our programs,
More news about: The Coordinating Center
Dec 16, 2025, 08:30 ET PhaseV Closes 2025 with Record Growth, Supporting Biopharma's Shift from AI Pilots to Full-Scale Execution
executed."2025 was the year of AI pilots and promises, but 2026 will bring wide-scale deployment and tangible impact to clinical development," said Raviv Pryluk, PhD, CEO and Co-founder of PhaseV. "Now is the time for pharma to fully embrace proven AI methodologies or risk being left behind. We are incredibly proud
More news about: PhaseV
Dec 16, 2025, 08:30 ET Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need
Milan Radovich, PhD, Senior Vice President and Chief Scientific Officer at Caris."Roche and Genentech are driven by a profound vision - a future where cancer can
More news about: Caris Life Sciences
Dec 16, 2025, 08:00 ET TSC Alliance Endowment Fund Invests in Aeovian Pharmaceuticals to Advance Development of an mTORC1 Selective Inhibitor for Tuberous Sclerosis Complex
Consortium as the preclinical efficacy engine throughout the lead development processto identify a novel clinical candidate," said Steven L. Roberds, PhD, Chief Scientific Officer at the TSC Alliance. "We are thrilled our early investment to create the TSC Preclinical Consortium and ongoing partnership
More news about: TSC Alliance
Dec 16, 2025, 07:30 ET REZOLVE-AA Phase 2b Study of Rezpegaldesleukin Establishes Proof-of-Concept in Patients with Severe-to-Very-Severe Alopecia Areata
mechanism, these results provide a compelling proof-of-concept for rezpegaldesleukin in a second inflammatory skin disease," said Jonathan Silverberg, MD, PhD, MPH, Professor of Dermatology at The George Washington University School of Medicine and Health Sciences. "As physicians, we have long been in search
More news about: Nektar Therapeutics
Dec 16, 2025, 07:00 ET Replicate Bioscience Appoints Kathy Fernando, Ph.D., as Chief Business Officer
multimedia:https://www.prnewswire.com/news-releases/replicate-bioscience-appoints-kathy-fernando-phd-as-chief-business-officer-302642485.htmlSOURCE
More news about: Replicate Bioscience
Dec 16, 2025, 07:00 ET RNAConnect Launches the UltraMarathonRT® Direct RNA‑Seq Kit to Advance Nanopore-based Native RNA Sequencing
RNAConnect's products enable discoveries across rare diseases, immunology, oncology, neurobiology, and beyond.Media Contact:Andrew Bond, PhD — Chief Commercial OfficerTel: +1‑475-338-2120Email: [email protected]
More news about: RNAConnect
Dec 16, 2025, 06:07 ET New Modeling Approach Sheds Light on Rare Gut Disease
accurate way to model Hirschsprung disease that will help us understand the disease in a way we could not before," said study first author Ryan Fine, PhD, a postdoctoral fellow at the Center for Human Genetics and Genomics at the NYU Grossman School of Medicine. "Our study shows for the first time how
More news about: NYU Langone Health System